Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-03, Stock:LLY, The news for the past five days is as follows:
2020-01-27: NEWS1: US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes.NEWS2: Eli Lilly Trading Near Top Of Buy Zone With Earnings On Tap.NEWS3: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS4: Lilly (LLY) to Report Q4 Earnings: What's in the Cards?.NEWS5: Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine.
2020-01-28: NEWS1: Merck's Dificid Gets FDA Approval in Pediatric Indication.NEWS2: AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study.NEWS3: Lilly's Olumiant Meets Primary Goal in Dermatitis Study.NEWS4: Dr. Reddy's (RDY) Q3 Earnings and Revenues Increase Y/Y.NEWS5: The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics.NEWS6: Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities.
2020-01-29: NEWS1: 5 Top Non-Tech Earnings Charts.NEWS2: Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review.NEWS3: Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More.NEWS4: Eli Lilly Reports Earnings Tomorrow. Here’s What to Expect..NEWS5: CVS to offer diabetes drugs at no out-of-pocket costs for PBM members.NEWS6: Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application.
2020-01-30: NEWS1: Lilly Fends Off Sagging Drug Prices To Post Its Best Growth In 2 Years.NEWS2: Lilly's NDA for Selpercatinib Gets FDA's Priority Review.NEWS3: Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up.NEWS4: Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity.NEWS5: Eli Lilly Stock Is Climbing After a Glowing Earnings Report.NEWS6: Eli Lilly (LLY) Tops Q4 Earnings & Sales, Keeps 2020 View.NEWS7: Slapping Around Martin Shkreli Won’t Cut Drug Prices.NEWS8: Eli Lilly Earnings Top; Drug Giant Rises.NEWS9: Eli Lilly's stock gains after earnings, revenue rise above expectations.NEWS10: Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition.NEWS11: Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis.NEWS12: Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz.NEWS13: Stocks - Facebook Slumps, Verizon Slips in Premarket, Tesla Surges.
2020-01-31: NEWS1: Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study.NEWS2: Edited Transcript of LLY earnings conference call or presentation 30-Jan-20 2:00pm GMT.NEWS3: Eli Lilly prices migraine therapy at $640 for pack of eight pills.NEWS4: Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription.NEWS5: Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative.NEWS6: Bayer Seeks FDA Approval for New Formulation of Nifurtimox.NEWS7: The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO.NEWS8: CHMP Recommends Approval of Lilly's New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes.

Answer: Rise